Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Hematological Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00606060
What this trial is testing

BAY14-2222 Continuous Infusion in Surgeries

Who this might be right for
Hemophilia
Bayer 15
Not applicableEnrolling By InvitationNCT07163260
What this trial is testing

Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia

Who this might be right for
Haemophilia
Novo Nordisk A/S 244
Not applicableStudy completedNCT02326597
What this trial is testing

Decision Aid for Therapeutic Options In Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell AnemiaHemoglobin SS+2 more
Emory University 134
Not applicableEnded earlyNCT04207320
What this trial is testing

Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Severe Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
University of Chicago 3
Large-scale testing (Phase 3)Ended earlyNCT00324324
What this trial is testing

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
OHSU Knight Cancer Institute 240
Testing effectiveness (Phase 2)Study completedNCT00001749
What this trial is testing

Medical Treatment for Diamond Blackfan Anemia

Who this might be right for
Fanconi's AnemiaHematologic Disease
National Heart, Lung, and Blood Institute (NHLBI) 25
Testing effectiveness (Phase 2)Study completedNCT00445978
What this trial is testing

The Effects of 6R-BH4 in Subjects With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
BioMarin Pharmaceutical 32
Not applicableUnknownNCT06276608
What this trial is testing

Iron Deficiency in Pediatric Heart Surgery

Who this might be right for
Iron DeficienciesIron Deficiency AnemiaCardiac Surgical Procedures+1 more
Queen Fabiola Children's University Hospital 300
Not applicableUnknownNCT02324517
What this trial is testing

Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders

Who this might be right for
Severe Hemophilia
Sheba Medical Center 300
Not applicableUnknownNCT01403740
What this trial is testing

Turkish Acquired Haemophilia Registry

Who this might be right for
Acquired Haemophilia
Turkish Society of Hematology 250
Not applicableUnknownNCT03946384
What this trial is testing

Mutation p.Ile112Thr : Discrepancy Between Factor IX Level and Bleeding Phenotype

Who this might be right for
Hemophilia B
Centre Hospitalier Universitaire Dijon 12
Not applicableLooking for participantsNCT04463316
What this trial is testing

GROWing Up With Rare GENEtic Syndromes

Who this might be right for
Prader-Willi SyndromePWS-like SyndromeSilver Russel Syndrome+30 more
dr. Laura C. G. de Graaff-Herder 600
Testing effectiveness (Phase 2)Ended earlyNCT04046848
What this trial is testing

Safety and Pharmacokinetics of Subcutaneous Injection of OCTA101 in Adult Patients With Severe Hemophilia A

Who this might be right for
Severe Hemophilia A
Octapharma 36
Large-scale testing (Phase 3)Study completedNCT01963143
What this trial is testing

Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases

Who this might be right for
Primary Immune Deficiency DisordersCommon Variable ImmunodeficiencyX-linked Agammaglobulinaemia+1 more
Bio Products Laboratory 48
Post-approval studies (Phase 4)Active Not RecruitingNCT05181618
What this trial is testing

Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis

Who this might be right for
Severe Hemophilia AModerate Hemophilia A
Hoffmann-La Roche 136
Not applicableStudy completedNCT04364685
What this trial is testing

Effect of Walking on Sand With Dietary Intervention in Overweight Type 2 Diabetes Mellitus Patients.

Who this might be right for
Walking, DifficultyDiabetes Mellitus, Type 2Hemoglobin; Hb-SC
Majmaah University 66
Not applicableLooking for participantsNCT06735625
What this trial is testing

Pilot Study "AHSP as a Biomarker of Sickle Cell Disease in a Population of Adults and Children"

Who this might be right for
in Relation to Sickle Cell Disease
Centre Hospitalier de Saint-Denis 100
Not applicableActive Not RecruitingNCT04406818
What this trial is testing

Metabolic and Hemodynamic Reserve in Pediatric SCA

Who this might be right for
Child, OnlyBrain DiseasesSickle Cell Disease+1 more
Washington University School of Medicine 120
Not applicableStudy completedNCT04244240
What this trial is testing

Links Between Cognitive Functions and Clinical, Biological and Neuroradiological Outcomes in Adults With Sickle Cell Disease.

Who this might be right for
Sickle Cell DiseaseDrepanocytosis
Hospices Civils de Lyon 19
Testing effectiveness (Phase 2)WithdrawnNCT01948817
What this trial is testing

Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses

Who this might be right for
Focus on Transfusion Dependent Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQD
Novartis Pharmaceuticals
Next Page